Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models

Archives of Toxicology

Volumn 89, Issue 11, 2015, Pages 1931-1957

  Cho, Hye Youn ^a   Kleeberger, Steven R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Antioxidant response element; Knockout mice; Lung; Nfe2l2; Oxidative stress

Indexed keywords

ALLERGEN; OVALBUMIN; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME;

ACUTE LUNG INJURY; ALLERGIC DISEASE; CANCER STAGING; CHEMICAL CARCINOGENESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCURRENT INFECTION; DOWNSTREAM PROCESSING; EXPERIMENTAL SEPSIS; GENETIC ASSOCIATION; GENETIC MODEL; HAEMOPHILUS INFECTION; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYPEROXIA; IN VIVO STUDY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DYSPLASIA; LUNG EMPHYSEMA; LUNG FIBROSIS; MOLECULAR PATHOLOGY; MOUSE MODEL; NEWBORN; NONHUMAN; ONCOGENE; POLLUTANT; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT DISEASE; REVIEW; VENTILATOR INDUCED LUNG INJURY; ANIMAL; ANTIOXIDANT RESPONSIVE ELEMENT; BIOLOGY; DISEASE MODEL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; KNOCKOUT MOUSE; MOUSE; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ACUTE LUNG INJURY; ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-E2-RELATED FACTOR 2; POLYMORPHISM, GENETIC; RESPIRATORY TRACT DISEASES;

EID: 84947618389     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-015-1557-y     Document Type: Review

References (203)

1. Adenuga D, Caito S, Yao H et al (2010) Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction. Biochem Biophys Res Commun 403(3–4):452–456. doi:10.1016/j.bbrc.2010.11.054
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303–1310
3. Aoki Y, Sato H, Nishimura N, Takahashi S, Itoh K, Yamamoto M (2001) Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol 173(3):154–160
4. Aoki Y, Hashimoto AH, Amanuma K et al (2007) Enhanced spontaneous and benzo(a)pyrene-induced mutations in the lung of Nrf2-deficient gpt delta mice. Cancer Res 67(12):5643–5648
5. Arisawa T, Tahara T, Shibata T et al (2008) The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium. Oncol Rep 19(1):211–216
6. Asikainen TM, Huang TT, Taskinen E et al (2002) Increased sensitivity of homozygous Sod2 mutant mice to oxygen toxicity. Free Radic Biol Med 32(2):175–186
7. Athale J, Ulrich A, Chou Macgarvey N et al (2012) Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic Biol Med 53(8):1584–1594. doi:10.1016/j.freeradbiomed.2012.08.009
8. Bakin AV, Stourman NV, Sekhar KR et al (2005) Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding phase II detoxifying proteins. Free Radic Biol Med 38(3):375–387
9. Baraldi E, Filippone M (2007) Chronic lung disease after premature birth. N Engl J Med 357(19):1946–1955
10. Barrios R, Shi ZZ, Kala SV et al (2001) Oxygen-induced pulmonary injury in gamma-glutamyl transpeptidase-deficient mice. Lung 179(5):319–330
11. Bauer AK, Cho HY, Miller-Degraff L et al (2011) Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice. PLoS One 6(10):e26590. doi:10.1371/journal.pone.0026590
12. Becker Y (2006) Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy–a review. Virus Genes 33(2):235–252
13. Behera AK, Matsuse H, Kumar M, Kong X, Lockey RF, Mohapatra SS (2001) Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection. Biochem Biophys Res Commun 280(1):188–195
14. Biswal S, Thimmulappa RK, Harvey CJ (2012) Experimental therapeutics of Nrf2 as a target for prevention of bacterial exacerbations in COPD. Proc Am Thorac Soc 9(2):47–51. doi:10.1513/pats.201201-009MS
15. Boelen A, Kwakkel J, Barends M, de Rond L, Dormans J, Kimman T (2002) Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice. J Med Virol 66(4):552–560
16. Bricker GV, Riedl KM, Ralston RA, Tober KL, Oberyszyn TM, Schwartz SJ (2014) Isothiocyanate metabolism, distribution, and interconversion in mice following consumption of thermally processed broccoli sprouts or purified sulforaphane. Mol Nutr Food Res 58(10):1991–2000. doi:10.1002/mnfr.201400104
17. Caballero MT, Serra ME, Acosta PL et al (2015) TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J Clin Invest 125(2):571–582. doi:10.1172/JCI75183
18. Canova C, Dunster C, Kelly FJ et al (2012) PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics. Epidemiology 23(4):607–615. doi:10.1097/EDE.0b013e3182572563
19. Casola A, Burger N, Liu T, Jamaluddin M, Brasier AR, Garofalo RP (2001) Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem 276(23):19715–19722
20. Castro SM, Guerrero-Plata A, Suarez-Real G et al (2006) Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am J Respir Crit Care Med 174(12):1361–1369
21. Chan K, Kan YW (1999) Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 96(22):12731–12736
22. Chan K, Lu R, Chang JC, Kan YW (1996) NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA 93(24):13943–13948
23. Chang AL, Ulrich A, Suliman HB, Piantadosi CA (2015) Redox regulation of mitophagy in the lung during murine Staphylococcus aureus sepsis. Free Radic Biol Med 78:179–189. doi:10.1016/j.freeradbiomed.2014.10.582
24. Cho HY (2013) Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2. Oxid Med Cell Longev 2013:286524. doi:10.1155/2013/286524
25. Cho HY, Jedlicka AE, Reddy SP et al (2002a) Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26(2):175–182
26. Cho HY, Jedlicka AE, Reddy SP, Zhang LY, Kensler TW, Kleeberger SR (2002b) Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. Am J Respir Cell Mol Biol 26(1):42–51
27. Cho HY, Reddy SP, Yamamoto M, Kleeberger SR (2004) The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18(11):1258–1260
28. Cho HY, Reddy SP, Debiase A, Yamamoto M, Kleeberger SR (2005) Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 38(3):325–343
29. Cho HY, Imani F, Miller-DeGraff L et al (2009) Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med 179(2):138–150
30. Cho HY, Gladwell W, Wang X et al (2010) Nrf2-regulated PPARγ expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med 182(2):170–182. doi:10.1164/rccm.200907-1047OC
31. Cho HY, van Houten B, Wang X et al (2012) Targeted deletion of Nrf2 impairs lung development and oxidant injury in neonatal mice. Antioxid Redox Signal. doi:10.1089/ars.2011.4288
32. Cho HY, Gladwell W, Yamamoto M, Kleeberger SR (2013) Exacerbated airway toxicity of environmental oxidant ozone in mice deficient in Nrf2. Oxid Med Cell Longev 2013:254069. doi:10.1155/2013/254069
33. Cho HY, Jedlicka AE, Gladwell W et al (2015a) Association of Nrf2 polymorphism haplotypes with acute lung injury phenotypes in inbred strains of mice. Antioxid Redox Signal 22(4):325–338. doi:10.1089/ars.2014.5942
34. Cho HY, Marzec J, Kleeberger SR (2015b) Functional polymorphisms in NRF2: implications for human disease. Free Radic Biol Med. doi:10.1016/j.freeradbiomed.2015.06.012
35. Clarke JD, Hsu A, Williams DE et al (2011) Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res. doi:10.1007/s11095-011-0500-z
36. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420(6917):885–891
37. Danel C, Erzurum SC, Prayssac P et al (1998) Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. Hum Gene Ther 9(10):1487–1496
38. Delgado-Buenrostro NL, Medina-Reyes EI, Lastres-Becker I et al (2014) Nrf2 protects the lung against inflammation induced by titanium dioxide nanoparticles: a positive regulator role of Nrf2 on cytokine release. Environ Toxicol. doi:10.1002/tox.21957
39. DeNicola GM, Karreth FA, Humpton TJ et al (2011) Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475(7354):106–109. doi:10.1038/nature10189
40. Domej W, Oettl K, Renner W (2014) Oxidative stress and free radicals in COPD-implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis 9:1207–1224. doi:10.2147/COPD.S51226
41. Eba S, Hoshikawa Y, Moriguchi T et al (2013) The nuclear factor erythroid 2-related factor 2 activator oltipraz attenuates chronic hypoxia-induced cardiopulmonary alterations in mice. Am J Respir Cell Mol Biol 49(2):324–333. doi:10.1165/rcmb.2011-0396OC
42. Egner PA, Chen JG, Zarth AT et al (2014) Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prevent Res 7(8):813–823. doi:10.1158/1940-6207.CAPR-14-0103
43. Eichenmuller M, Trippel F, Kreuder M et al (2014) The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 61(6):1312–1320. doi:10.1016/j.jhep.2014.08.009
44. Erickson AM, Nevarea Z, Gipp JJ, Mulcahy RT (2002) Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence. J Biol Chem 277(34):30730–30737
45. Fahey JW, Zhang Y, Talalay P (1997) Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 94(19):10367–10372
46. Fahey JW, Wehage SL, Holtzclaw WD et al (2012) Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer Prevent Res 5(4):603–611. doi:10.1158/1940-6207.CAPR-11-0538
47. Fattman CL, Chang LY, Termin TA, Petersen L, Enghild JJ, Oury TD (2003) Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med 35(7):763–771
48. Feitelson MA, Arzumanyan A, Kulathinal RJ et al (2015) Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Semin Cancer Biol. doi:10.1016/j.semcancer.2015.02.006
49. Figarska SM, Vonk JM, Boezen HM (2014) NFE2L2 polymorphisms, mortality, and metabolism in the general population. Physiol Genom 46(12):411–417. doi:10.1152/physiolgenomics.00178.2013
50. Fitzpatrick AM, Stephenson ST, Hadley GR et al (2011) Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2. J Allergy Clin Immunol 127(6):1604–1611. doi:10.1016/j.jaci.2011.03.031
51. Folz RJ, Abushamaa AM, Suliman HB (1999) Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 103(7):1055–1066
52. Foy HM, Cooney MK, Maletzky AJ, Grayston JT (1973) Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period. Am J Epidemiol 97(2):80–92
53. Fridovich I (1998) Oxygen toxicity: a radical explanation. J Exp Biol 201(Pt 8):1203–1209
54. Gebel S, Gerstmayer B, Bosio A, Haussmann HJ, Van Miert E, Muller T (2004) Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke. Carcinogenesis 25(2):169–178
55. −/− mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes. Toxicol Sci 115(1):238–252. doi:10.1093/toxsci/kfq039
56. Gerhauser C, You M, Liu J et al (1997) Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res 57(2):272–278
57. Goss CH, Brower RG, Hudson LD, Rubenfeld GD (2003) Incidence of acute lung injury in the United States. Crit Care Med 31(6):1607–1611
58. Hackett NR, Heguy A, Harvey BG et al (2003) Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 29(3 Pt 1):331–343
59. Shaheen SO, Newson RB, Ring SM, Rose-Zerilli MJ, Holloway JW, Henderson AJ (2010) Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol 126(6):1141-8 e7. doi:10.1016/j.jaci.2010.08.047
60. Halliwell B, Gutteridge JM, Cross CE (1992) Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 119(6):598–620
61. Harvey CJ, Thimmulappa RK, Singh A et al (2009) Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 46(4):443–453. doi:10.1016/j.freeradbiomed.2008.10.040
62. Harvey CJ, Thimmulappa RK, Sethi S et al (2011) Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Trans Med 3(78):78ra32. doi:10.1126/scitranslmed.3002042
63. Hayes JD, McMahon M (2009) NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 34(4):176–188
64. Heber D, Li Z, Garcia-Lloret M et al (2014) Sulforaphane-rich broccoli sprout extract attenuates nasal allergic response to diesel exhaust particles. Food Funct 5(1):35–41. doi:10.1039/c3fo60277j
65. Hecker L, Logsdon NJ, Kurundkar D et al (2014) Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Trans Med 6(231):231ra47. doi:10.1126/scitranslmed.3008182
66. Ho YS, Vincent R, Dey MS, Slot JW, Crapo JD (1998) Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 18(4):538–547
67. Hosakote YM, Jantzi PD, Esham DL et al (2011) Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 183(11):1550–1560. doi:10.1164/rccm.201010-1755OC
68. Hoshino T, Nakamura H, Okamoto M et al (2003) Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am J Respir Crit Care Med 168(9):1075–1083
69. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138–150. doi:10.1056/NEJMra021333
70. Houghton CA, Fassett RG, Coombes JS (2013) Sulforaphane: translational research from laboratory bench to clinic. Nutr Rev 71(11):709–726. doi:10.1111/nure.12060
71. Hu Y, Ju Y, Lin D et al (2012) Mutation of the Nrf2 gene in non-small cell lung cancer. Mol Biol Rep 39(4):4743–4747. doi:10.1007/s11033-011-1266-4
72. Hudak BB, Zhang LY, Kleeberger SR (1993) Inter-strain variation in susceptibility to hyperoxic injury of murine airways. Pharmacogenetics 3(3):135–143
73. Hybertson BM, Gao B, Bose SK, McCord JM (2011) Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 32(4–6):234–246. doi:10.1016/j.mam.2011.10.006
74. Iizuka T, Ishii Y, Itoh K et al (2005) Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 10(12):1113–1125
75. Ishida R, Takahashi T (1975) Increased DNA chain breakage by combined action of bleomycin and superoxide radical. Biochem Biophys Res Commun 66(4):1432–1438
76. Ishii Y, Itoh K, Morishima Y et al (2005) Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J Immunol 175(10):6968–6975
77. Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M (1995) Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 15(8):4184–4193
78. Itoh K, Chiba T, Takahashi S et al (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236(2):313–322
79. Itoh K, Ye P, Matsumiya T, Tanji K, Ozaki T (2015) Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria. J Clin Biochem Nutr 56(2):91–97. doi:10.3164/jcbn.14-134
80. Jardine H, MacNee W, Donaldson K, Rahman I (2002) Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1. J Biol Chem 277(24):21158–21166
81. Jean JC, Liu Y, Brown LA, Marc RE, Klings E, Joyce-Brady M (2002) Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. Am J Physiol Lung Cell Mol Physiol 283(4):L766–L776
82. Jiang T, Huang Z, Chan JY, Zhang DD (2009) Nrf2 protects against As(III)-induced damage in mouse liver and bladder. Toxicol Appl Pharmacol 240(1):8–14. doi:10.1016/j.taap.2009.06.010
83. Jin W, Wang H, Yan W et al (2009) Role of Nrf2 in Protection against Traumatic Brain Injury in Mice. J Neurotrauma 26:131–139
84. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723–1729
85. Keith RL, Karoor V, Mozer AB, Hudish TM, Le M, Miller YE (2010) Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression. Lung Cancer 70(1):37–42. doi:10.1016/j.lungcan.2010.01.004
86. Kensler TW, Egner PA, Agyeman AS et al (2013) Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top Curr Chem 329:163–177. doi:10.1007/128_2012_339
87. Kesic MJ, Simmons SO, Bauer R, Jaspers I (2011) Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic Biol Med 51(2):444–453. doi:10.1016/j.freeradbiomed.2011.04.027
88. Kikuchi N, Ishii Y, Morishima Y et al (2010) Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 11:31. doi:10.1186/1465-9921-11-31
89. Kikuchi N, Ishii Y, Morishima Y et al (2011) Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I. Am J Respir Cell Mol Biol 45(3):600–609. doi:10.1165/rcmb.2010-0137OC
90. Kim HS, Manevich Y, Feinstein SI, Pak JH, Ho YS, Fisher AB (2003) Induction of 1-cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 285(2):L363–L369
91. Kim YR, Oh JE, Kim MS et al (2010) Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol 220(4):446–451. doi:10.1002/path.2653
92. Kim KH, Kwun MJ, Han CW, Ha KT, Choi JY, Joo M (2014) Suppression of lung inflammation in an LPS-induced acute lung injury model by the fruit hull of Gleditsia sinensis. BMC Complement Altern Med 14:402. doi:10.1186/1472-6882-14-402
93. Kumar H, Kim IS, More SV, Kim BW, Choi DK (2014) Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases. Nat Prod Rep 31(1):109–139. doi:10.1039/c3np70065h
94. Kurt-Jones EA, Popova L, Kwinn L et al (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1(5):398–401
95. Kwak MK, Kensler TW (2010) Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol 244(1):66–76. doi:10.1016/j.taap.2009.08.028
96. Li YJ, Takizawa H, Azuma A et al (2008) Disruption of Nrf2 enhances susceptibility to airway inflammatory responses induced by low-dose diesel exhaust particles in mice. Clin Immunol 128(3):366–373
97. Li YJ, Takizawa H, Azuma A et al (2010) Nrf2 is closely related to allergic airway inflammatory responses induced by low-dose diesel exhaust particles in mice. Clin Immunol 137(2):234–241
98. Li N, Wang M, Barajas B, Sioutas C, Williams MA, Nel AE (2013) Nrf2 deficiency in dendritic cells enhances the adjuvant effect of ambient ultrafine particles on allergic sensitization. J Innate Immun 5(6):543–554. doi:10.1159/000347060
99. Lin P, Hsueh YM, Ko JL, Liang YF, Tsai KJ, Chen CY (2003) Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer 40(2):123–129
100. Liu RM, Liu Y, Forman HJ, Olman M, Tarpey MM (2004a) Glutathione regulates transforming growth factor-beta-stimulated collagen production in fibroblasts. Am J Physiol Lung Cell Mol Physiol 286(1):L121–L128
101. Liu T, Castro S, Brasier AR, Jamaluddin M, Garofalo RP, Casola A (2004b) Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases. J Biol Chem 279(4):2461–2469
102. London SJ, Yuan JM, Chung FL et al (2000) Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356(9231):724–729
103. Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
104. Lugade AA, Vethanayagam RR, Nasirikenari M, Bogner PN, Segal BH, Thanavala Y (2011) Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae. Am J Respir Cell Mol Biol 45(3):557–565. doi:10.1165/rcmb.2010-0321OC
105. Machtay M, Scherpereel A, Santiago J et al (2006) Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse. Radiother Oncol 81(2):196–205
106. Mak JC, Leung HC, Ho SP et al (2006) Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy 36(4):440–447. doi:10.1111/j.1365-2222.2006.02458.x
107. Malhotra D, Thimmulappa R, Navas-Acien A et al (2008) Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 178(6):592–604
108. Manar MH, Brown MR, Gauthier TW, Brown LA (2004) Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 24(1):30–35. doi:10.1038/sj.jp.7211020
109. Mapp CE, Fryer AA, De Marzo N et al (2002) Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J Allergy Clin Immunol 109(5):867–872
110. Markart P, Luboeinski T, Korfei M et al (2009) Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. Antioxid Redox Signal 11(2):227–240
111. Martin F, van Deursen JM, Shivdasani RA, Jackson CW, Troutman AG, Ney PA (1998) Erythroid maturation and globin gene expression in mice with combined deficiency of NF-E2 and nrf-2. Blood 91(9):3459–3466
112. Marzec JM, Christie JD, Reddy SP et al (2007) Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 21(9):2237–2246
113. Masuko H, Sakamoto T, Kaneko Y et al (2011a) An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study. BMC Med Genet 12:97. doi:10.1186/1471-2350-12-97
114. Masuko H, Sakamoto T, Kaneko Y et al (2011b) Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes. Int J Chron Obstruct Pulmon Dis 6:181–189. doi:10.2147/COPD.S16383
115. Mata M, Ruiz A, Cerda M et al (2003) Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J 22(6):900–905
116. Matthay MA, Ware LB, Zimmerman GA (2012) The acute respiratory distress syndrome. J Clin Invest 122(8):2731–2740. doi:10.1172/JCI60331
117. Matthias C, Bockmuhl U, Jahnke V et al (1998) Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 8(2):91–100
118. McClellan RO (1987) Health effects of exposure to diesel exhaust particles. Annu Rev Pharmacol Toxicol 27:279–300
119. McGrath-Morrow S, Lauer T, Yee M et al (2009) Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 296(4):L565–L573
120. McGrath-Morrow SA, Lauer T, Collaco JM et al (2014) Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status. Cytokine 65(1):4–9. doi:10.1016/j.cyto.2013.09.021
121. Messier EM, Bahmed K, Tuder RM, Chu HW, Bowler RP, Kosmider B (2013a) Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke. Cell Death Dis 4:e573. doi:10.1038/cddis.2013.96
122. Messier EM, Day BJ, Bahmed K et al (2013b) N-acetylcysteine protects murine alveolar type II cells from cigarette smoke injury in a nuclear erythroid 2-related factor-2-independent manner. Am J Respir Cell Mol Biol 48(5):559–567. doi:10.1165/rcmb.2012-0295OC
123. Michaeloudes C, Chang PJ, Petrou M, Chung KF (2011) Transforming growth factor-beta and nuclear factor E2-related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma. Am J Respir Crit Care Med 184(8):894–903. doi:10.1164/rccm.201011-1780OC
124. Minai OA, Chaouat A, Adnot S (2010) Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):39S–51S. doi:10.1378/chest.10-0087
125. Mochizuki M, Ishii Y, Itoh K et al (2005) Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am J Respir Crit Care Med 171(11):1260–1266
126. Moore ML, Peebles RS Jr (2006) Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther 112(2):405–424
127. Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP (2003) UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124(7):1802–1808
128. Ohta T, Iijima K, Miyamoto M et al (2008) Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 68(5):1303–1309
129. Ojesina AI, Lichtenstein L, Freeman SS et al (2014) Landscape of genomic alterations in cervical carcinomas. Nature 506(7488):371–375. doi:10.1038/nature12881
130. O’Mahony DS, Glavan BJ, Holden TD et al (2012) Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study. PLoS One 7(12):e51104. doi:10.1371/journal.pone.0051104
131. Ooi A, Dykema K, Ansari A et al (2013) CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma. Cancer Res 73(7):2044–2051. doi:10.1158/0008-5472.CAN-12-3227
132. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM (1999) Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103(7):1047–1054
133. Padmanabhan B, Tong KI, Ohta T et al (2006) Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 21(5):689–700
134. Papaiahgari S, Yerrapureddy A, Reddy SR et al (2007) Genetic and pharmacologic evidence links oxidative stress to ventilator-induced lung injury in mice. Am J Respir Crit Care Med 176(12):1222–1235
135. Papp D, Lenti K, Modos D et al (2012) The NRF2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops. FEBS Lett 586(13):1795–1802. doi:10.1016/j.febslet.2012.05.016
136. Pardo A, Ruiz V, Arreola JL et al (2003) Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. Am J Respir Crit Care Med 167(6):925–932
137. Pendyala S, Moitra J, Kalari S et al (2011) Nrf2 regulates hyperoxia-induced Nox4 expression in human lung endothelium: identification of functional antioxidant response elements on the Nox4 promoter. Free Radic Biol Med 50(12):1749–1759. doi:10.1016/j.freeradbiomed.2011.03.022
138. Poggi C, Dani C (2014) Antioxidant strategies and respiratory disease of the preterm newborn: an update. Oxid Med Cell Longev 2014:721043. doi:10.1155/2014/721043
139. Powers KA, Szaszi K, Khadaroo RG et al (2006) Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 203(8):1951–1961
140. Putila JJ, Guo NL (2011) Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS One 6(10):e25886. doi:10.1371/journal.pone.0025886
141. Rangasamy T, Cho CY, Thimmulappa RK et al (2004) Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114(9):1248–1259
142. Rangasamy T, Guo J, Mitzner WA et al (2005) Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202(1):47–59
143. Rangasamy T, Williams MA, Bauer S et al (2010) Nuclear erythroid 2 p45-related factor 2 inhibits the maturation of murine dendritic cells by ragweed extract. Am J Respir Cell Mol Biol 43(3):276–285. doi:10.1165/rcmb.2008-0438OC
144. Reddy NM, Kleeberger SR, Kensler TW, Yamamoto M, Hassoun PM, Reddy SP (2009a) Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J Immunol 182(11):7264–7271
145. Reddy NM, Suryanaraya V, Yates MS et al (2009b) The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice. Am J Respir Crit Care Med 180(9):867–874
146. Reddy NM, Suryanarayana V, Kalvakolanu DV et al (2009c) Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice. J Immunol 183(7):4601–4608
147. Reddy NM, Potteti HR, Mariani TJ, Biswal S, Reddy SP (2011) Conditional deletion of Nrf2 in airway epithelium exacerbates acute lung injury and impairs the resolution of inflammation. Am J Respir Cell Mol Biol 45(6):1161–1168. doi:10.1165/rcmb.2011-0144OC
148. Reiss LK, Fragoulis A, Siegl S et al (2014) Interplay between nuclear factor erythroid 2-related factor 2 and amphiregulin during mechanical ventilation. Am J Respir Cell Mol Biol 51(5):668–677. doi:10.1165/rcmb.2013-0279OC
149. Rushmore TH, Morton MR, Pickett CB (1991) The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266(18):11632–11639
150. Sampath V, Garland JS, Helbling D et al (2015) Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants. Pediatr Res 77(3):477–483. doi:10.1038/pr.2014.200
151. Sasaki H, Suzuki A, Shitara M et al (2013a) Genotype analysis of the NRF2 gene mutation in lung cancer. Int J Mol Med 31(5):1135–1138. doi:10.3892/ijmm.2013.1324
152. Sasaki H, Suzuki A, Shitara M et al (2013b) Polymorphisms of NRF2 gene correlated with decreased FEV1 in lung cancers of smokers. Biomed Rep 1(3):484–488. doi:10.3892/br.2013.83
153. Satoh H, Moriguchi T, Taguchi K et al (2010) Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis 31(10):1833–1843. doi:10.1093/carcin/bgq105
154. Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M (2013) Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res 73(13):4158–4168. doi:10.1158/0008-5472.CAN-12-4499
155. Saugstad OD (2003) Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 8(1):39–49
156. Shibata T, Ohta T, Tong KI et al (2008) Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 105(36):13568–13573
157. Shibata T, Kokubu A, Saito S et al (2011) NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia 13(9):864–873
158. Siedlinski M, Postma DS, Boer JM et al (2009) Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population. Respir Res 10:73. doi:10.1186/1465-9921-10-73
159. Siegel D, Ross D (2000) Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 29(3–4):246–253
160. Singh A, Misra V, Thimmulappa RK et al (2006a) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 3(10):e420
161. Singh A, Rangasamy T, Thimmulappa RK et al (2006b) Glutathione peroxidase 2, the major cigarette smoke-inducible isoform of GPX in lungs, is regulated by Nrf2. Am J Respir Cell Mol Biol 35(6):639–650
162. Singh A, Ling G, Suhasini AN et al (2009) Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med 46(3):376–386
163. Slocum SL, Kensler TW (2011) Nrf2: control of sensitivity to carcinogens. Arch Toxicol 85(4):273–284. doi:10.1007/s00204-011-0675-4
164. Sriram N, Kalayarasan S, Sudhandiran G (2008) Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther 22(3):221–236
165. Sussan TE, Rangasamy T, Blake DJ et al (2009) Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci USA 106(1):250–255
166. Sussan TE, Gajghate S, Chatterjee S et al (2015) Nrf2 reduces allergic asthma in mice through enhanced airway epithelial cytoprotective function. Am J Physiol Lung Cell Mol Physiol. doi:10.1152/ajplung.00398.2014
167. Suzuki M, Betsuyaku T, Ito Y et al (2008) Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 39(6):673–682
168. Taguchi K, Maher JM, Suzuki T, Kawatani Y, Motohashi H, Yamamoto M (2010) Genetic analysis of cytoprotective functions supported by graded expression of Keap1. Mol Cell Biol 30(12):3016–3026. doi:10.1128/MCB.01591-09
169. Taguchi K, Motohashi H, Yamamoto M (2011) Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16(2):123–140. doi:10.1111/j.1365-2443.2010.01473.x
170. Talalay P, Fahey JW (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131(11 Suppl):3027S–3033S
171. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y (1995) Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82–83:173–179
172. Tan XL, Spivack SD (2009) Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: a review. Lung Cancer 65:129–137
173. Tan DS, Wang W, Leong HS et al (2014) Tongue carcinoma infrequently harbor common actionable genetic alterations. BMC Cancer 14:679. doi:10.1186/1471-2407-14-679
174. Tanase AM, Marchio A, Dumitrascu T et al (2014) Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome. J Epo Sci Environ Epidemiol. doi:10.1038/jes.2014.16
175. Taniguchi H, Kondoh Y (2013) Combination therapies targeting multiple pathways in idiopathic pulmonary fibrosis (IPF). Intern Med 52(22):2481–2482
176. Tao S, Zheng Y, Lau A et al (2013) Tanshinone I activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Antioxid Redox Signal 19(14):1647–1661. doi:10.1089/ars.2012.5117
177. Taylor JL, Carraway MS, Piantadosi CA (1998) Lung-specific induction of heme oxygenase-1 and hyperoxic lung injury. Am J Physiol 274(4 Pt 1):L582–L590
178. Taylor RC, Acquaah-Mensah G, Singhal M, Malhotra D, Biswal S (2008) Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress. PLoS Comput Biol 4(8):e1000166
179. Thimmulappa RK, Lee H, Rangasamy T et al (2006a) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116(4):984–995
180. Thimmulappa RK, Scollick C, Traore K et al (2006b) Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Biochem Biophys Res Commun 351(4):883–889
181. Tian L, White JE, Lin HY et al (1998) Induction of Mn SOD in human monocytes without inflammatory cytokine production by a mutant endotoxin. Am J Physiol 275(3 Pt 1):C740–C747
182. Travis EL, Rachakonda G, Zhou X et al (2011) NRF2 deficiency reduces life span of mice administered thoracic irradiation. Free Radic Biol Med 51(6):1175–1183. doi:10.1016/j.freeradbiomed.2011.05.038
183. Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ (2001) CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2(8):732–738
184. Turei D, Papp D, Fazekas D et al (2013) NRF2-ome: an integrated web resource to discover protein interaction and regulatory networks of NRF2. Oxid Med Cell Longev 2013:737591. doi:10.1155/2013/737591
185. Ungvari I, Hadadi E, Virag V et al (2012) Relationship between air pollution, NFE2L2 gene polymorphisms and childhood asthma in a Hungarian population. J Community Genet 3(1):25–33. doi:10.1007/s12687-011-0075-8
186. Van Rheen Z, Fattman C, Domarski S et al (2011) Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol 44(4):500–508. doi:10.1165/rcmb.2010-0065OC
187. van Schaik SM, Obot N, Enhorning G et al (2000) Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Med Virol 62(2):257–266
188. Vomhof-Dekrey EE, Picklo MJ Sr (2012) The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. J Nutr Biochem 23(10):1201–1206. doi:10.1016/j.jnutbio.2012.03.005
189. Wakabayashi N, Itoh K, Wakabayashi J et al (2003) Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 35(3):238–245
190. Walter J, Ware LB, Matthay MA (2014) Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. Lancet Respir Med 2(12):1016–1026. doi:10.1016/S2213-2600(14)70217-6
191. Walters DM, Cho HY, Kleeberger SR (2008) Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxid Redox Signal 10(2):321–332
192. Wang Y, Feinstein SI, Manevich Y, Ho YS, Fisher AB (2004) Lung injury and mortality with hyperoxia are increased in peroxiredoxin 6 gene-targeted mice. Free Radic Biol Med 37(11):1736–1743
193. Wang X, Tomso DJ, Chorley BN et al (2007) Identification of polymorphic antioxidant response elements in the human genome. Hum Mol Genet 16(10):1188–1200
194. Wang X, Chorley BN, Pittman GS et al (2010) Genetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer. PLoS One 5(8):e11934. doi:10.1371/journal.pone.0011934
195. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342(18):1334–1349
196. Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA (2006) Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291(3):L307–L311
197. Wasserman WW, Fahl WE (1997) Functional antioxidant responsive elements. Proc Natl Acad Sci USA 94(10):5361–5366
198. Williams MA, Rangasamy T, Bauer SM et al (2008) Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter. J Immunol 181(7):4545–4559
199. Yageta Y, Ishii Y, Morishima Y et al (2011) Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J Virol 85(10):4679–4690. doi:10.1128/JVI.02456-10
200. Ying YH, Lin XP, Zhou HB et al (2014) Nuclear erythroid 2 p45-related factor-2 Nrf2 ameliorates cigarette smoking-induced mucus overproduction in airway epithelium and mouse lungs. Microbes Infect 16(10):855–863. doi:10.1016/j.micinf.2014.08.014
201. Zhang Y, Callaway EC (2002) High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J 364(Pt 1):301–307
202. Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P (1994) Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 91(8):3147–3150
203. Zheng Y, Tao S, Lian F et al (2012) Sulforaphane prevents pulmonary damage in response to inhaled arsenic by activating the Nrf2-defense response. Toxicol Appl Pharmacol 265(3):292–299. doi:10.1016/j.taap.2012.08.028